StegPGDormanSHAmarencoP. Atherothrombosis and the role of antiplatelet therapy. J Thromb Haemost. 2011;9:325–32.
2.
CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996;348:1329–39.
3.
WallentinLBeckerRCBudajA, et al.Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045–57.
4.
WiviottSDBraunwaldEMcCabeCH, et al.Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357:2001–15.
5.
BinsalehNKWigleyCAWhiteheadKA, et al.Thieno[2,3-b]pyridine derivatives are potent anti-platelet drugs, inhibiting platelet activation, aggregation and showing synergy with aspirin. Eur J Med Chem. 2018;143:1997–2004.
6.
KolessovVI. Mammary artery-coronary artery anastomosis as method of treatment for angina pectoris. J Thorac Cardiovasc Surg. 1967;54:535–44.
7.
FavaloroRG. Saphenous vein autograft replacement of severe segmental coronary artery occlusion: operative technique. Ann Thorac Surg. 1968;5:334–9.
8.
GomesWJAngeliniGD. On- or off-pump coronary artery bypass surgery. is the debate settling down?Braz J Cardiovasc Surg. 2019;34:VIII–XI.
9.
PrapasSNPangiotopoulosIALeivaditisVN, et al.The pi-circuit technique in coronary surgery: analysis of 1359 consecutive cases. Open J Cardiovasc Surg. 2019;11:1179065219871948.
10.
KhanMSIslamMYAhmedMUBawanyFIKhanAArshadMH. On pump coronary artery bypass graft surgery versus off pump coronary artery bypass graft surgery: a review. Glob J Health Sci. 2014;6:186–93.
ChengYLiuXZhaoY, et al.Risk factors for postoperative events in patients on antiplatelet therapy undergoing off-pump coronary artery bypass grafting surgery [published online 15 April 2020]. Angiology. doi: 10.1177/0003319720919319.
13.
JanssenPWAClaassensDMFWillemsenLMBergmeijerTOKleinPTen BergJM. Perioperative management of antiplatelet treatment in patients undergoing isolated coronary artery bypass grafting in Dutch cardiothoracic centres. Neth Heart J. 2017;25:482–9.
14.
KremkeMTangMBakM, et al.Antiplatelet therapy at the time of coronary artery bypass grafting: a multicentre cohort study. Eur J Cardiothorac Surg. 2013;44:e133–40.
15.
MiceliADugganSMAresuG, et al.Combined clopidogrel and aspirin treatment up to surgery increases the risk of postoperative myocardial infarction, blood loss and reoperation for bleeding in patients undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg. 2013;43:722–8.
16.
HolmMBiancariFKhodabandehS, et al.Bleeding in patients treated with ticagrelor or clopidogrel before coronary artery bypass grafting. Ann Thorac Surg. 2019;107:1690–8.
17.
HanssonECJideusLAbergB, et al.Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study. Eur Heart J. 2016;37:189–97.
18.
TomsicASchotborghMAManshandenJSLiWWDe MolBA. Coronary artery bypass grafting-related bleeding complications in patients treated with dual antiplatelet treatment. Eur J Cardiothorac Surg. 2016;50:849–56.
19.
NeumannFJSousa-UvaMAhlssonA, et al.2018 ESC/EACTS Guidelines on myocardial revascularization. EuroIntervention. 2019;14:1435–534.
